CIK 0001439222 · Large accelerated filer
AGIOS PHARMACEUTICALS, INC.
Sign in to watch- Ticker
- AGIO
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- Phone
- 617-649-8600
- Business address
- 88 SIDNEY STREET, CAMBRIDGE, MA, 02139
- Former names
- AGIOS PHARMACEUTICALS INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $371,112
- in 2 filings, $371K under 10b5-1 plans
Net −$371,112. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2019-05-29 | MARAGANORE JOHN Director | Grant or award · Restricted stock units | +1,878 | 1,878 | ||
| 2019-05-29 | Ho Maykin Director | Grant or award · Stock option (right to buy) | +8,919 | 8,919 | ||
| 2019-05-29 | Ho Maykin Director | Grant or award · Restricted stock units | +1,878 | 1,878 | ||
| 2019-05-29 | Foster-Cheek Kaye I Director | Grant or award · Stock option (right to buy) | +8,919 | 8,919 | ||
| 2019-05-29 | Foster-Cheek Kaye I Director | Grant or award · Restricted stock units | +1,878 | 1,878 | ||
| 2019-05-29 | CLARK IAN T Director | Grant or award · Stock option (right to buy) | +8,919 | 8,919 | ||
| 2019-05-29 | CLARK IAN T Director | Grant or award · Restricted stock units | +1,878 | 1,878 | ||
| 2019-05-29 | Clancy Paul J Director | Grant or award · Stock option (right to buy) | +8,919 | 8,919 | ||
| 2019-05-29 | Clancy Paul J Director | Grant or award · Restricted stock units | +1,878 | 1,878 | ||
| 2019-04-22 | Hirsch Andrew Chief Financial Officer | Grant or award · Restricted stock units | +17,678 | 17,678 | ||
| 2019-04-05 | Biller Scott Chief Scientific Officer | Option exercise | +3,000 | $39.76 | $119K | 29,511 |
| 2019-04-05 | Biller Scott Chief Scientific Officer | Sale | −2,401 | $67.61 | $162K | 27,110 |
| 2019-04-05 | Biller Scott Chief Scientific Officer | Sale | −599 | $68.12 | $41K | 26,511 |
| 2019-04-05 | Biller Scott Chief Scientific Officer | Option exercise · Stock option (right to buy) | −3,000 | 39,648 | ||
| 2019-04-01 | Bowden Christopher Chief Medical Officer | Option exercise | +10,000 | $35.16 | $352K | 17,238 |
| 2019-04-01 | Bowden Christopher Chief Medical Officer | Sale | −5,854 | $66.03 | $387K | 11,384 |
| 2019-04-01 | Bowden Christopher Chief Medical Officer | Sale | −2,546 | $66.85 | $170K | 8,838 |
| 2019-04-01 | Bowden Christopher Chief Medical Officer | Sale | −1,500 | $68.09 | $102K | 7,338 |
| 2019-04-01 | Bowden Christopher Chief Medical Officer | Sale | −100 | $68.72 | $7K | 7,238 |
| 2019-04-01 | Bowden Christopher Chief Medical Officer | Option exercise · Stock option (right to buy) | −10,000 | 71,000 |
Page 52 of 63 · 1,252 trades